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Serum opacity factor promotes group A streptococcal epithelial cell invasion and
virulence
Abstract
Serum opacity factor (SOF) is a bifunctional cell surface protein expressed by 40-50% of group A
streptococcal (GAS) strains comprised of a C-terminal domain that binds fibronectin and an N-terminal
domain that mediates opacification of mammalian sera. The sof gene was recently discovered to be cotranscribed in a two-gene operon with a gene encoding another fibronectin-binding protein, sfbX. We
compared the ability of a SOF(+) wild-type (WT) serotype M49 GAS strain and isogenic mutants lacking
SOF or SfbX to invade cultured HEp-2 human pharyngeal epithelial cells. Elimination of SOF led to a
significant decrease in HEp-2 intracellular invasion while loss of SfbX had minimal effect. The
hypoinvasive phenotype of the SOF(-) mutant could be restored upon complementation with the sof gene
on a plasmid vector, and heterologous expression of sof49 in M1 GAS or Lactococcus lactis conferred
marked increases in HEp-2 cell invasion. Studies using a mutant sof49 gene lacking the
fibronectinbinding domain indicated that the N-terminal opacification domain of SOF contributes to HEp-2
invasion independent of the C-terminal fibronectin binding domain, findings corroborated by observations
that a purified SOF N-terminal peptide could promote latex bead adherence to HEp- 2 cells and inhibit GAS
invasion of HEp-2 cells in a dose-dependent manner. Finally, the first in vivo studies to employ a single
gene allelic replacement mutant of SOF demonstrate that this protein contributes to GAS virulence in a
murine model of necrotizing skin infection.
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SUMMARY

Serum opacity factor (SOF) is a bifunctional cell surface protein expressed by 40-50% of
group A streptococcal (GAS) strains comprised of a C-terminal domain that binds fibronectin
and an N-terminal domain that mediates opacification of mammalian sera. The sof gene was
recently discovered to be co-transcribed in a two-gene operon with a gene encoding another
fibronectin-binding protein, sfbX. We compared the ability of a SOF(+) wild-type (WT) serotype
M49 GAS strain and isogenic mutants lacking SOF or SfbX to invade cultured HEp-2 human
pharyngeal epithelial cells.

Elimination of SOF led to a significant decrease in HEp-2

intracellular invasion while loss of SfbX had minimal effect. The hypoinvasive phenotype of the
SOF(-) mutant could be restored upon complementation with the sof gene on a plasmid vector,
and heterologous expression of sof49 in M1 GAS or Lactococcus lactis conferred marked
increases in HEp-2 cell invasion. Studies using a mutant sof49 gene lacking the fibronectinbinding domain indicated that the N-terminal opacification domain of SOF contributes to HEp-2
invasion independent of the C-terminal fibronectin binding domain, findings corroborated by
observations that a purified SOF N-terminal peptide could promote latex bead adherence to HEp2 cells and inhibit GAS invasion of HEp-2 cells in a dose-dependent manner. Finally, the first in
vivo studies to employ a single gene allelic replacement mutant of SOF demonstrate that this
protein contributes to GAS virulence in a murine model of necrotizing skin infection.
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INTRODUCTION

Group A Streptococcus (GAS) is responsible for a wide spectrum of human disease, from
simple pharyngitis to serious invasive infections including necrotizing fasciitis and toxic shock
syndrome. Approximately half of GAS strains are capable of opacifying mammalian serum, a
unique phenotype attributable to the presence of serum opacity factor (SOF) encoded by the sof
gene (Beall et al., 2000; Kreikemeyer et al., 1995). SOF is a 110-kDa protein with an LP(X)SG
cell wall anchor motif expressed in both membrane bound and extracellular forms (Courtney et
al., 1999; Katerov et al., 2000; Rakonjac et al., 1995). SOF is a bifunctional protein comprised
of an N-terminal opacification domain, and C-terminal domain of highly conserved tandem
repeat sequences capable of binding the host extracellular matrix components fibronectin and
fibrinogen (Courtney et al., 2002; Kreikemeyer et al., 1999; Rakonjac et al., 1995). Once
thought to be a lipoproteinase, SOF has recently been shown to bind apoA-I and apoA-II, causing
release of HDL lipid cargo, which in turn coalesces to form lipid droplets, resulting in serum
opacification (Courtney et al., 2006b).

Studies with SOF-coated latex beads indicate the protein can promote adherence to
human HEp-2 pharyngeal epithelial cells including fibronectin-specific interactions (Oehmcke et
al., 2004). A role in GAS virulence has been attributed to SOF, since insertional inactivation of
the sof gene in a serotype 2 GAS isolate reduced mortality in a mouse intraperitoneal infection
model (Courtney et al., 1999). SOF also triggers host production of opsonic antibodies that
protect against infection by SOF(+) strains of GAS, suggesting it may represent a useful vaccine
antigen (Courtney et al., 2003).
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The sof gene is recently recognized to be a member of a two gene operon, invariably cotranscribed with a gene encoding a second surface anchored protein, sfbX (Jeng et al., 2003). SfbX
possesses a C-terminal domain of tandem repeat sequences very highly homologous to the
fibronectin-binding domain of SOF, but a unique N-terminal domain. SfbX is capable of binding
fibronectin, but the function of its N-terminal sequences has yet to be elucidated (Jeng et al.,
2003). Given previous insertional mutagenesis studies targeting sof were performed before the
operon structure was recognized, polar effects on sfbX would be anticipated, and the precise
contribution of each individual gene is therefore uncertain.

In this study, we utilize nonpolar allelic replacement mutants of sof and sfbX, coupled
with heterologous expression of each gene, to study their contribution(s) to GAS epithelial cell
invasion and animal virulence. Unexpectedly, our results uncovered a key contribution of the
N-terminal SOF opacification domain to GAS cellular invasion independent of the C-terminal
fibronectin-binding motifs.
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RESULTS

SOF and not SfbX contributes to epithelial cell invasion by M49 GAS

Allelic replacement mutants of M49 GAS lacking SOF or SfbX were compared to the
WT parent strain for their ability to invade cultured monolayers of HEp-2 human pharyngeal
epithelial cells in vitro. In the graphical representation of our results, photo insets depicting the
serum opacity phenotype of the individual bacterial strains are provided within the corresponding
bars. As measured by antibiotic protection assay, the isogenic ΔSOF mutant exhibited a 50%
decrease in cellular invasion (P = 0.0002). The invasion phenotype of the ΔSOF mutant could
be restored above WT levels by return of the single sof gene on a multicopy number
complementation plasmid (P < 0.0001) (Fig. 1). The isogenic ΔSfbX mutant did not differ
significantly from WT GAS in HEp-2 cell invasiveness (P = 0.255) (Fig. 1). As SOF and SfbX
share highly homologous C-terminal fibronectin-binding repeat domains, these results provided a
first clue that N-terminal sequences in the “opacification” domain of SOF could possess unique
properties facilitating cellular invasion.

Gain of function analysis by heterologous expression of SOF and SfbX

To determine if sof and sfbX are sufficient to confer increased invasion of epithelial cells,
expression vectors for each GAS M49 gene were transformed into bacteria lacking this operon.
Under the standard assay condition, overexpression of sof49 in GAS M1 strain 5448 increased
Hep2-cell invasion 100-fold, while overexpression of sfbX produced a 10-fold gain in invasion
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frequency (Fig. 2A). When parallel studies of heterologous expression were performed in L.
lactis, which lacks significant fibronectin binding, sof conferred a nearly 1,000-fold increase in
HEp-2 cell invasion compared to a 10-fold increase for sfbX (Fig. 2B). These analyses in
heterologous bacterial strains are also consistent with the key role of SOF, but not SfbX, in
epithelial cell invasion by GAS (Fig. 1).

Visualization of SOF-dependent bacterial uptake in HEp-2 cells

To corroborate observed differences in HEp-2 cell invasion detected in the antibiotic
protection assays, fluorescence techniques were used to differentiate surface bound and
intracellular bacteria. Bacteria were strained with calcein-AM (green) prior to use in a standard
HEp-2 cell invasion assay as above, but at the assay end point the fluorescence of external
bacteria was quenched with ethidium bromide (red). As seen in Fig. 3, significantly fewer ΔSOF
mutant GAS were observed inside HEp-2 cells compared to the WT parent strain. Likewise, the
number of M1 GAS and L. lactis internalized by HEp-2 cells were significantly increased when
these bacteria expressed the cloned M49 sof gene (Fig. 3).

The N-terminal enzymatic domain of SOF contributes to epithelial cell invasion
independently of the C-terminal fibronectin-binding domain.

We observed in our mutagenesis and heterologous expression studies that SOF
contributed much more significantly than SfbX to epithelial cell invasion (Figs. 1, 2), though
both proteins possess homologous C-terminal fibronectin-binding domains. We hypothesized
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that the N-terminal enzymatic domain of SOF must therefore play a direct role in promoting
epithelial cell invasion. To test this hypothesis, we generated an in-frame deletion of the entire
fibronectin-binding repeat domain of SOF within our expression plasmid (pAT-SOFΔFn) to
produce a truncated derivative of the protein that maintained opacification activity. Plasmid
pAT-SOFΔFn expressing the truncated SOFΔFn protein was observed to complement the
invasion defect of the M49 NZ131Δsof mutant to WT levels (Fig. 4a), and to confer a 100-fold
increase in epithelial cell invasion when expressed in L. lactis (Fig. 4b). To corroborate these
findings, the opacification domain of GAS SOF75, lacking the fibronectin-binding repeats, was
expressed in E. coli and purified (SOF75ΔFn). Addition of the exogenous SOF75ΔFn peptide
produced a dose-dependent inhibition of HEp-2 cell invasion by a WT SOF(+) M75 GAS strain
(Fig. 5a), consistent with competitive inhibition of a GAS-host cell interaction mediated by
surface-bound SOF. When complexed to latex beads, the same SOF75ΔFn peptide promoted
tight adherence of the beads to HEp-2 cells as visualized by scanning electron microscopy (Fig.
5b). Taken together, these results indicate that the N-terminal opacification domain of SOF
contributes to epithelial cell invasion independently of the C-terminal fibronectin-binding
domain.

Correlation of SOF with HEp-2 cell invasiveness among GAS strains

To ascertain whether the observed contribution of SOF to GAS invasiveness in our
molecular genetic studies could be reflected broadly across strains of varying SOF phenotype,
we studied a panel of GAS strains of various emm (M protein) genotypes from the Centers for
Disease Control including both SOF(+) (n = 26) and SOF(-) (n = 19) types. These strains were
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screened for invasion of HEp-2 cells in a 96-well format modification of the standard assay (Fig.
6). Mean intracellular cfu recovered from the SOF(+) strains was 130,274 compared to 50,233
for the SOF(-) strains; median values were 55,150 for the SOF(+) strains and 29,700 for the
SOF(-) strains. A significant positive correlation was thus apparent between GAS expression of
SOF and invasiveness in HEp-2 epithelial cells (P = 0.025).

SOF contributes to GAS virulence in murine infection

The specific contribution of SOF to GAS virulence was tested in murine models of
infection. In Fig. 7A, Kaplan-Myer survival curves were established for groups of 10 male CD1
mice challenged by intraperitoneal (I.P.) injection with 2 x 107 cfu of either the WT M49 GAS
strain or its isogenic ΔSOF and ΔSfbX mutants. No difference was seen between the WT strain
and the ΔSfbX mutant, with 100% mortality by day 3-4; a slight delay in the kinetics of killing of
the ΔSOF mutant was observed with 25% of mice surviving and asymptomatic at the end of the
10 d assessment period. SOF was next expressed heterologously in the WT M1 GAS strain, and
groups of 12 mice compared to vector only control using an I.P. challenge dose of 2 x 106 cfu.
An increase in mortality from 50% to 75% was observed by 10 d (Fig. 7b). As the observed
tendencies following loss or gain of SOF did not reach statistical significance, we conducted a
further assessment of the contribution of SOF to GAS virulence in a murine subcutaneous
infection model. Sixteen male CD1 mice were shaved and injected subcutaneously in one flank
with the WT GAS M49 strain and in the contralateral flank with an equivalent dose of the
isogenic ΔSOF mutant. In this way, each mouse served as its own control. The development of
necrotic ulcers was monitored and lesion area calculated at day 7 (Fig. 8a). Lesions produced
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by the WT strain were larger in 12/16 mice, lesions equivalent in size in 3/16 mice, and in only
1/16 mice was the lesion produced by the ΔSOF mutant larger. The lesions were excised and the
cfu/gm skin tissue calculated by plating dilutions of the tissue homogenate. Bacterial counts
were significantly (P = 0.002) higher for the WT strain compared to the ΔSOF mutant in 14/16
mice, with a median 7.7-fold increase of cfu/gm tissue recovered for the WT strain (Fig. 8b).
Photos of two representative animals from the skin challenge experiment are shown in Fig. 8c.
Our results confirm a unique contribution of SOF to GAS virulence independent of SfbX and are
the first to demonstrate a role of SOF in GAS pathogenicity using a localized infection model.
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DISCUSSION

SOF is a unique bifunctional protein produced by many GAS strains and possesses roles
in host cell interaction, immunogenicity, and disease pathogenesis. Here we have used isogenic
mutants and heterologous expression to show for the first time that SOF promotes GAS invasion
of human pharyngeal epithelial cells and contributes to GAS virulence independent of the coexpressed SfbX protein.

The affinity of several GAS surface anchored proteins to fibronectin and other
extracellular matrix components has been shown to play a major role in the organism’s
adherence to and invasion of host epithelial cell surfaces (Hanski and Caparon, 1992;
Kreikemeyer et al., 1995; Molinari et al., 1997; Rocha and Fischetti, 1999). Our experiments
with a domain deletion construct and purified protein reagent demonstrate that the N-terminal
enzymatic domain of SOF, in addition to its activity in serum opacification, possesses distinct
pro-invasive properties. The N-terminal domain of SOF thus may cooperate with the C-terminal
fibronectin-binding repeats in promoting GAS-host cell interactions. We found SfbX, with
homologous C-terminal repeats to SOF, can confer increased invasion in the L. lactis
background where fibronectin-binding is otherwise absent. However, deletion of sfbX was
insufficient to impair invasion of GAS, where the presence of additional fibronectin-binding
surface molecules may provide compensation.

The sof/sfbX operon is located approximately 10 kb from the tandemly-linked genes of
the GAS mga regulon on a 5,500 bp fragment that appears in sof positive strains as a precise
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insertion relative to the same chromosomal region of sof-negative M1, M3, and M18 strains
(Jeng et al., 2003). There is a strict correlation of the presence of sof with specific emm sequence
types. It is interesting that this strict correlation is observed, even though many emm types are
shared by sof-positive strains that have unrelated sof genes and multilocus sequence types (Beall
et al., 2000). Expression of sof/sfbX is influenced by the multiple gene regulator (mga) that lies
closely upstream of emm and controls several GAS virulence genes involved in colonization,
cellular invasion and immune resistance (McIver and Myles, 2002); mga has recently been
shown to bind to a specific promoter element upstream of sof/sfbX in a fashion sufficient to
activate transcription (Almengor et al., 2006). We found specific deletion of SOF in the M49
GAS background significantly reduced virulence in the mouse model of necrotizing skin
infection. The importance of SOF in this model may reflect contributions not only to host cell
adherence and intracellular invasion, but also to enhanced resistance to phagocytic clearance, as
recently demonstrated in human whole blood killing assays (Courtney et al., 2006a).

GAS strains have been defined as belonging to either class I or class II M types based on
epitopes present within the conserved C repeat region of M proteins (Bessen et al., 1989; Bessen
and Fischetti, 1990) and the architecture of the mga regulon (Haanes et al., 1992).

The

expression of SOF is found exclusively in Class II GAS (Bessen et al., 1989). Given that SOF is
expressed by only a subset of GAS strains (40-50%) the opacity factor is not a requirement for
virulence in all GAS strains. However, this study found that specific deletion of SOF in the Class
II M49 GAS background significantly reduced virulence in the mouse model of necrotizing skin
infection. Different GAS strains express a wide array of surface anchored proteins that interact
with components of the extracellular matrix (Ramachandran et al., 2004), and a number of these
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have been shown to play a role in adherence of the organism to host epithelial cell surfaces and
the invasion of the GAS bacterium into these cells (Caparon et al., 1991; Courtney et al., 1997;
Hanski and Caparon, 1992; Jaffe et al., 1996; Kreikemeyer et al., 2004; Molinari et al., 1997;
Wang and Stinson, 1994). Differential expression of multiple adhesins in response to varying
environmental cues and extracellular matrix components at specific tissue sites may be important
for colonization of a tissue specific site. Thus, SOF may represent a critical virulence factor of
Class II SOF(+) GAS, the absence of which in Class I GAS may be compensated for by the
presence of other fibronectin-binding surface adhesins.

In summary, our studies demonstrate that SOF can contribute to epithelial cell invasion
and animal virulence in the approximately 50% of clinical isolates that express this protein.
Previous assumptions that interactions with the host cell were mediated predominantly through
the C-terminal repeat domains should now be reconsidered, as both opacification and promotion
of host cell invasion appear to be mediated by the SOF N-terminal domain.
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EXPERIMENTAL PROCEDURES

Bacterial strains and culture conditions. Serotype M49 GAS strain NZ131 is a
well-characterized T14 SOF(+) strain originally isolated from the skin of a patient with
glomerulonephritis (Simon and Ferretti, 1991).

Isogenic mutants NZ131ΔSOF and

NZ131ΔSfbX contain a precise, in-frame allelic replacement of the corresponding open reading
frame with a chloramphenicol acetylase (cat) gene marker (Jeng et al., 2003). Serotype M1 GAS
strain 5448 is a T1, SOF(-) isolate from a patient with necrotizing fasciitis and toxic shock
syndrome (Kansal et al., 2000). Lactococcus lactis strain NZ9000 is derived from MG1363 and
lacks the nis operon (Kuipers et al., 1998). SOF and SfbX amplified from NZ131 were cloned in
vector pDCerm to yield plasmids pAJ-SOF and pAJ-SfbX (Jeng et al., 2003), and used to
transform M1 GAS 5448 and L. lactis for heterologous expression studies in comparison to
vector only controls. GAS were grown in Todd-Hewitt broth (THB), on Todd-Hewitt agar plates
(THA), or on plates of Trypticase Soy Agar + 5% sheep red blood cells (SBA). Antibiotic
selection for plasmid maintenance utilized 2 µg/ml of erythromycin (Em) for GAS and 5 µg/ml
Em for L. lactis. To prepare log phase GAS for use in tissue culture assays or animal infections,
bacteria were grown to OD600 = 0.4 = 2 x 108 cfu/ml at 37oC, pelleted, washed, resuspended and
diluted in PBS or tissue culture media to the desired concentration. L. lactis was prepared as
above (OD600 = 0.4 = 108 cfu/ml)but incubation performed at 30oC.

Serum opacification assays. Bacteria were grown to stationary phase overnight, pelleted by
centrifugation, and 100 µl of supernatant added to 1ml of heat inactivated (55°C, 30 min) horse
serum (Gibco) in a 24-well cell culture plate. The plate was rocked for 15 min, sealed in a plastic
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bag with moisture, and incubated overnight at 37°C. Opacification was observed and
photographed on a dark background.

Epithelial cell invasion assays. Human pharyngeal epithelial cells (HEp-2) were obtained from
ATCC and propagated as monolayers in RPMI 1640 (Mediatech) supplemented with 10% FBS +
2 mM L-glutamine + 100µM non-essential amino acids at 37°C with 5% CO2. For assays, HEp2 cells were plated at 2 x 105 cells/well in one mL of media in a tissue culture treated 24 well
plate and incubated at 37°C x 24 h. Bacterial cultures were inoculated from a single colony and
grown overnight in THB with corresponding antibiotic selection. The following day, cultures
were diluted 1:10 in fresh THB without antibiotics to an OD600nm of 0.4 (~2 x 108 cfu/ml).
Immediately prior to assay, the culture media on the HEp-2 cells was replaced with fresh RPMI
1640 + 2% FBS. Bacteria were diluted in PBS and 2 x 106 cfu added to each well for a
multiplicity of infection of 10:1 (bacteria:cell). The plate was centrifuged at 800 x g x 5 min to
ensure contact of the bacteria with the cell monolayer, then incubated at 37°C in 5% CO2. After
2 h, monolayers were washed x 3 with PBS to remove unattached bacteria. Media containing
antibiotics (100 µg/ml gentamicin + 10 µg/ml penicillin) was added to each well, and the plates
incubated an additional 2 h to kill extracellular bacteria. The wells were washed again, and 100
µl of trypsin added to each well for 3-5 minutes at 37°C to facilitate cell detachment. Triton-X
100 was added to each well at a final concentration of 0.025% and triturated with a micropipette
for 20 sec to liberate intracellular bacteria. Dilutions were plated on THB at 37°C overnight for
enumeration of cfu. All assays were carried out in triplicate and repeated 4-6 times.
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Fluorescence microscopy.

HEp-2 cells were prepared as described in the invasion assay

protocol. Bacteria were grown to an OD600nm of 0.3 (GAS) or 0.2 (L. lactis), then 1 ml pelleted
by centrifugation at 10,000 x g. Bacteria were resuspended in 100 μl PBS + 10% THB, 0.5 µl 10
mM calcein-AM (Molecular Probes) added, and staining carried out for 1 h at 37oC (GAS) or 2 h
at 30°C (L. lactis). Stained bacteria were washed x 3 with PBS to remove residual calcein-AM,
resuspended in 1 ml PBS, 100 µl added to each HEp-2 monolayer, the plate centrifuged, and
incubated for 2 h at 37oC to allow for internalization. After incubation, wells were washed with
PBS, counterstained for 1-3 min with 100 μg/ml ethidium bromide, and washed again.
Fluorescence was visualized with a Nikon TE200 inverted microscope using a green filter, a red
filter, and white light. Images were captured with a CCD camera and assembled using Adobe
Photoshop Creative Suite 2.

Construction and expression of pAT-SOFΔ Fn. This plasmid was generated by modification of
pAJ-sof (Jeng et al., 2003) through inverse PCR and blunt-end ligation. Primers were designed
(fwd: 5’-ttcttccactttgataacgag-3’, rev: 5’-ggcagtaatggattcaatgga-3’) to create an inverse PCR
product that consisted of the entire plasmid and gene, excluding the C-terminal fibronectin
binding repeat region (residues 831Q to 960R). The resultant PCR product was purified (Qiagen
Gel Extraction Kit), blunt-end ligated for 2 h at RT using Invitrogen T4 ligase and used to
transform E. coli MC1061 with selection for Em resistance. Resultant plasmid pAT-SOFΔFn
was purified and confirmed by restriction analysis and direct sequencing. The pAT-SOFΔFn
was used to transform the GAS M49 ΔSOF mutant and L. lactis by electroporation at 1700
volts, recovery in THB 0.25% sucrose, and Em selection. Transformants were confirmed by
PCR analysis and gain of serum opacification phenotype.
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Survey of GAS clinical strains for correlation between SOF phenotype and HEp-2 cell
invasion. Single representatives of 45 different emm types were obtained from invasive isolates
collected through the Centers for Disease Control Active Bacterial Core surveillance program in
the United States during 2002-2004 (see http://www.cdc.gov/ncidod/dbmd/abcs/). These isolates
were collected from patients of a wide age range (<1 to >90 years) and varied geographic
locations, that represented a wide range of clinical manifestations. Strains were grown in 200 ml
within individual wells of a 96-well plate with passage over 2 nights prior to use in the assay.
HEp-2 cells were plated in a 96-well tissue culture treated plate at 4x104 cells/well in 200 ml of
media and incubated x 24 h. On the day of the assay, 18 h stationary phase GAS cultures were
serially diluted 1:100 in 96 well plates in RPMI 2% FBS, then 100 ml added to the HEp-2 cell
monolayers in quadruplicate wells for each strain. The balance of the study was carried out as for
the standard invasion assay, with serial dilutions plated on THB for enumeration of cfu.

Expression and purification of recombinant SOF75Δ Fn protein. A His6-tagged fusion protein
of residues 33 to 872 of SOF from M75 GAS strain (lacking signal sequence and fibronectinbinding repeat region, SOF75ΔFn) was constructed using the pQE30 vector system
(Kreikemeyer et al., 1999).

Large-scale expression and purification of SOF75ΔFn was

conducted essentially according to manufacturer’s instructions (Qiagen, Chatsworth, CA).
Briefly, recombinant protein was expressed in E. coli M15 (pREP4)(pSOF75ΔFn), 1L culture in
LB was grown to mid-log phase, and protein expression was induced by the addition of IPTG to
a final concentration of 1mM and incubation for a further 4 h at 37oC with shaking. Cells were
harvested by centrifugation at 4000 x g for 20 minutes at 4oC and cell pellets stored at -20oC
overnight prior to protein extraction and purification. Large-scale purification of (His6)-tagged
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SOF75ΔFn was performed using Ni-NTA chromatography under denaturing conditions
according to manufacturer’s instructions (Qiagen, Chatsworth, CA). To ensure slow buffer
exchange for refolding of the denatured proteins, the proteins were initially dialysed against 2
changes of 0.5-1 L PBS followed by 2 changes of 3 L PBS. To ensure correct refolding of
proteins was achieved, purified proteins were subsequently tested for opacity factor activity
using an agarose overlay method (Kreikemeyer et al., 1999). The SOF75ΔFn protein was added
at the specified concentration to HEp-2 monolayers 1 h prior to inoculation with an SOF75(+)
WT GAS strain, then maintained throughout the first 2 h incubation step of the invasion assay.

Interaction of SOF coated latex beads with HEp-2 cells. As per previously published methods
(Dombek et al., 1999; Molinari et al., 1997), latex beads (3 μm; Sigma-Aldrich, St. Louis, MO)
were coated with purified recombinant SOF75ΔFn. Briefly, 108 bead particles in 50 μl of PBS
were incubated with 5 μg of purified protein in PBS overnight at 4°C. After washing steps, free
binding sites on the bead surface were blocked by incubation with 200 μl of 10 mg/ml BSA in
PBS for 1 h at room temperature. Followed by washing and resuspension in a final volume of 1
ml Dulbecco modified Eagle medium (DMEM) (Invitrogen, Karlsruhe, Germany) with HEPES
and 1% fetal calf serum (FCS). The efficiency of protein loading was verified by incubation of
~2 x 107 coated beads with polyclonal anti-SOF75 rabbit serum (diluted 1:1000 PBS + 5 mg/ml
BSA) (Gillen et al., 2002) followed by washing in PBS and incubation with goat anti-rabbit
Alexa 488 (green) (50 µl of a 1:40 dilution in PBS + 5 mg/ml BSA) (Molecular Probes, Eugene,
OR) for 1 h at room temperature and subsequently washed with PBS. Bead fluorescence was
then visualized by fluorescent microscopy (Zeiss inverted microscope x100 M), where 100% of
observed beads were coated with protein (data not shown). HEp-2 cells were seeded on 12-mm-
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diameter glass coverslips (Nunc, Wiesbaden, Germany) placed on the bottom of 24-well tissue
culture plates (Nunc, Wiesbaden, Germany) at 2 × 105 cells per well and allowed to grow in
DMEM supplemented with 10% FCS (FCS; GIBCO), 5 mM glutamine (FlowLaboratories, Inc.,
McLean, Va.), penicillin (100 U/ml), and streptomycin (100 mg/ml) to semi-confluent
monolayers at 37°C in a 5% CO2 atmosphere. Cells were washed twice with DMEM HEPES,
and 500 μl of DMEM HEPES + 1% FCS was added to the cells followed by the addition of 200
μl of the bead suspension and incubation for 2 h at 37°C in a 5% CO2 atmosphere. Cells were
washed vigorously with PBS to remove unbound beads and processed for scanning electron
microscopy.

Electron microscopy studies. Cells were fixed in a solution containing 3% glutaraldehyde and
5% formaldehyde in cacodylate buffer for 45 min on ice and then washed with cacodylate buffer.
For scanning electron microscopy, samples were dehydrated in a graded series of acetone and
subjected to critical-point drying with CO2. Samples were then covered with a 10-nm-thick gold
film and examined with a Zeiss 982 Gemini digital scanning microscope.

Mouse infection models. For systemic challenges, 10-week old male CD-1 mice were infected
intraperitoneally with the specified dose of GAS strains (2 x 107 cfu for WT GAS M49 and
isogenic mutants, 2 x 106 cfu for WT M1 GAS and transformant expressing SOF49) in 5%
mucin. Mortality was monitored and recorded for a 10-day period. An established model of
GAS necrotizing subcutaneous infection was also used (Buchanan et al., 2006; Datta et al.,
2005). Briefly, logarithmic phase GAS mutant were pelleted, resuspended in PBS, diluted 1:1
with sterile Cytodex beads (Sigma), and injected subcutaneously at the specificed dose in 100 µl
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volume into shaved 10-week-old male CD-1 mice. WT SOF(+) GAS strain M49 was injected
into one flank and its isogenic ΔSOF mutant simultaneously in the opposite flank for direct
comparison in each mouse. The developing lesion sizes were measured daily. At the end of the
experiment, mice were sacrificed, the lesion removed by excisional biopsy, homogenized, and
serially diluted in PBS for plating on THA and enumeration of CFU/lesion.

Statistical analyses: Data sets were compared by Student’s T-test using the Microsoft Excel
statistical package; a P value < 0.05 was considered significant.
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FIGURE LEGENDS:

Figure 1: Invasion of HEp-2 human pharyngeal epithelial cells by WT M49 GAS strain NZ131,
isogenic allelic replacement mutants lacking either SOF or SfbX, and each mutant
complemented by replacement of the corresponding gene on a plasmid vector. Figure insets
show serum opacification phenotype of each tested strain.

Figure 2. Invasion of HEp-2 human pharyngeal epithelial cells upon heterologous expression of
the sof and sfbX genes from M49 GAS in (A) M1 GAS that normally lacks the corresponding
operon and (B) Lactococcus lactis strain NZ9000. Figure insets show serum opacification
phenotype of each tested strain.

Figure 3: Fluorescent imaging demonstrating the contribution of SOF to interactions with HEp2 epithelial cell monolayers. Decreased intracellular invasion seen upon deletion of SOF from
WT SOF(+) GAS and increased intracellular invasion observed upon heterologous expression of
SOF in WT SOF(-) GAS and Lactococcus lactis.

Figure 4. Deletion of the fibronectin-binding domain of SOF protein does not eliminate the
contribution of SOF to HEp-2 epithelial cell invasion as tested in (A) complementation studies
using the M49 GAS ΔSOF mutant and (B) heterologous expression studies in Lactococcus lactis.
Figure insets show serum opacification phenotype of each tested strain.
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Figure 5.

(A)

An SOF peptide lacking the fibronectin-binding repeats produces a dose-

dependent inhibition of HEp-2 epithelial cell invasion by WT SOF(+) GAS; (B) An SOF peptide
lacking fibronectin-binding repeats promotes adherence of latex beads to HEp-2 cells.

Figure 6. Survey of panel of 45 GAS strains of varying M-protein (emm) genotypes reveals a
correlation of SOF-positivity with increased capacity for HEp-2 cell invasion.

Figure 7. Effect of deletion of SOF or SfbX on mouse survival in an intraperitoneal challenge
model using an SOF(+) M49 WT parent strain; (B) Effect of heterologous expression of SOF in
the M1 GAS background on mouse survival in the same challenge model.

Figure 8. Effect of deletion of SOF on GAS virulence in a murine skin infection model,
including (A) decreased lesion size (B) decreased bacterial counts in the infected skin tissues.
(C) Representative images of necrotic lesions developing in animals infected using this model.
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